Health IT

Researchers made embryonic stem cell claims (Morning Read)

The two researchers whose claims of injury led a federal judge to ban research using human embryonic stem cells late Monday have a history of disputes with colleagues as well as ethical objections to embryonic stem cell research, according to the New York Times.

Highlights of the important and interesting in the world of healthcare:

Embryonic stem cell activists. The two researchers whose claims of injury led a federal judge to ban research using human embryonic stem cells late Monday have a history of disputes with colleagues as well as ethical objections to embryonic stem cell research, according to the New York Times.

Health IT to the rescue. Can health information technology transform the U.S. economy? asks the Health Populi blog. The White House thinks so.

Actos as problematic as Avandia. A study published in Circulation, the journal of the American Heart Association, found that Takeda Pharmaceutical’s diabetes drug Actos causes as many heart problems as Avandia, the GlaxoSmithKline pill that has been linked to higher heart-disease rates, Bloomberg BusinessWeek is reporting.

String of quality problems. Johnson & Johnson, the venerable Band-Aid company that already has recalled tens of millions of bottles of pediatric medicines now is recalling millions of one-day Acuvue contact lenses. The Pharmalot blog has started a J&J recall watch.

Choose your own reviewer. National Academy of Sciences researchers have linked chronic fatigue syndrome to a class of virus that is similar to HIV. But the paper on the link has its own story, the Wall Street Journal Health blog reports.

presented by

Lights! Camera! Action! Computers and digital cameras and medical devices help “tele-caregivers” play a starring role in enabling senior citizens to remain in their own homes as they age, according to an NPR report.

Photo credit: National Science Foundation